ClinicalTrials.gg
CompletedNCT01086137Updated Aug 7, 2013

Biomarkers of Metabolic Syndrome and Prediabetes

An observational study in Metabolic Syndrome, Diabetes and Prediabetes, sponsored by West Virginia School of Osteopathic Medicine. Completed at 1 site in United States. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-08-07.

Sponsored by West Virginia School of Osteopathic Medicine · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
102
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 578 studies in Metabolic Syndrome with a site in United States — 62 open to participants now, 84 under way, 3 of them phase 3. Metabolic Syndrome · United States.

Enrollment
51st of 86
102 · median 141
Started
2010
with 24 others
Observational
86 of 578
12 open now
Registered
193rd of 578
by date

Among the 578 studies in Metabolic Syndrome with a site in United States, this one is the 51st largest by enrollment of the 86 observational ones that give a count, is one of 25 that started in 2010, is one of 86 observational ones, and was the 193rd registered.

Metabolic Syndrome

2,119 studies on the registry are indexed under Metabolic Syndrome; 350 are open to participants now.

Browse Metabolic Syndrome studies →

Open to participants now

62 of the 578 studies in Metabolic Syndrome with a site in United States are open now. Recruiting first, the newest first:

57 more — sign in →

All 62 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 234 Metabolic Syndrome studies recruiting now, 70 (30%) set no upper age limit and 135 (58%) stop at 75 or younger; 20 take children under 18; 81 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 578 studies in Metabolic Syndrome with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to investigate the feasibility of using salivary biomarkers to screen for complications of metabolic syndrome including prediabetes.

03

Conditions studied

  • Metabolic Syndrome
  • Diabetes
  • Prediabetes
  • Hypertension

Keywords

  • salivary biomarker
  • metabolic syndrome
  • prediabetes
  • diabetes hypertension
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

community sample

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between the ages of 18 and 65 years
  • Males and females will be included in this study
  • All ethnic backgrounds will be included in this study
  • Acceptable health based on interview and medical history
  • Ability to comply with requirements of the study
  • Ability and willingness to provide signed

Exclusion criteria

Exclusion Criteria:

  • Eating or drinking anything but water within 10 hours of sample collection
  • disease
  • Type 1 diabetes
  • Pregnancy (\< 6 weeks postpartum)
  • History of Sjorgren's Syndrome
  • Dental work within the last two weeks
  • Ongoing or active parasitic, fungal, viral or bacterial infection
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Autoimmune disease

A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.

Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
102 participants (actual)
Biospecimen retention
Samples with dna
06

What researchers measure

Primary outcomes

  1. Salivary Biomarker Levels

    Time frame: baseline

07

Study locations

1 site
  • West Virginia School of Osteopathic Medicine
    Lewisburg, West Virginia 24901, United States
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Mar 2010, a primary completion of Dec 2011 and a completion of Dec 2011. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2010
First posted
Mar 12, 2010
Start
Mar 2010
Primary completionActual
Dec 2011
CompletionActual
Dec 2011
Last update
Aug 7, 2013
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01086137
Lead sponsor
West Virginia School of Osteopathic Medicine
Responsible party
Kristie Bridges (Associate Professor, West Virginia School of Osteopathic Medicine) — Principal investigator
First posted
Mar 12, 2010
Start date
Mar 2010
Primary completion
Dec 2011
Completion
Dec 2011
Last update
Aug 7, 2013

Study contacts

Kristie G Bridges, PhD
principal investigator · WVSOM
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion